220 related articles for article (PubMed ID: 10496304)
1. The potential application of ribozymes for the treatment of hematological disorders.
James HA
J Leukoc Biol; 1999 Sep; 66(3):361-8. PubMed ID: 10496304
[TBL] [Abstract][Full Text] [Related]
2. Oligonucleotide therapeutics: clothing the emperor.
Gewirtz AM
Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
[TBL] [Abstract][Full Text] [Related]
3. Nucleic acid therapeutics: state of the art and future prospects.
Gewirtz AM; Sokol DL; Ratajczak MZ
Blood; 1998 Aug; 92(3):712-36. PubMed ID: 9680338
[No Abstract] [Full Text] [Related]
4. Utility of antioncogene ribozymes and antisense oligonucleotides in reversing drug resistance.
Funato T
Methods Mol Med; 2005; 106():215-33. PubMed ID: 15375319
[No Abstract] [Full Text] [Related]
5. Hammerhead ribozymes for target validation.
Goodchild J
Expert Opin Ther Targets; 2002 Apr; 6(2):235-47. PubMed ID: 12223083
[TBL] [Abstract][Full Text] [Related]
6. Antisense strategy: biological utility and prospects in the treatment of hematological malignancies.
Warzocha K; Wotowiec D
Leuk Lymphoma; 1997 Jan; 24(3-4):267-81. PubMed ID: 9156656
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic antisense and ribozymes.
Rossi JJ
Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide-mediated modulation of mammalian gene expression.
Scanlon KJ; Ohta Y; Ishida H; Kijima H; Ohkawa T; Kaminski A; Tsai J; Horng G; Kashani-Sabet M
FASEB J; 1995 Oct; 9(13):1288-96. PubMed ID: 7557018
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes.
Lavrovsky Y; Chen S; Roy AK
Biochem Mol Med; 1997 Oct; 62(1):11-22. PubMed ID: 9367793
[TBL] [Abstract][Full Text] [Related]
10. Anti-gene therapy: the use of ribozymes to inhibit gene function.
Couture LA; Stinchcomb DT
Trends Genet; 1996 Dec; 12(12):510-5. PubMed ID: 9257533
[TBL] [Abstract][Full Text] [Related]
11. Antisense therapy.
Narayanan R; Akhtar S
Curr Opin Oncol; 1996 Nov; 8(6):509-15. PubMed ID: 8971471
[TBL] [Abstract][Full Text] [Related]
12. Ribozymes: a modern tool in medicine.
Khan AU; Lal SK
J Biomed Sci; 2003; 10(5):457-67. PubMed ID: 12928586
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
Nakata Y; Kim TK; Shetzline S; Gewirtz AM
Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
[TBL] [Abstract][Full Text] [Related]
14. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
[TBL] [Abstract][Full Text] [Related]
15. Antisense inhibition: oligonucleotides, ribozymes, and siRNAs.
Zhang YC; Taylor MM; Samson WK; Phillips MI
Methods Mol Med; 2005; 106():11-34. PubMed ID: 15375310
[No Abstract] [Full Text] [Related]
16. Antisense strategies for the treatment of hematological malignancies and solid tumors.
Kronenwett R; Haas R
Ann Hematol; 1998; 77(1-2):1-12. PubMed ID: 9760146
[TBL] [Abstract][Full Text] [Related]
17. Oligomeric nucleic acids as antivirals.
Mescalchin A; Restle T
Molecules; 2011 Jan; 16(2):1271-96. PubMed ID: 21278679
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotides as therapeutic agents.
Alama A; Barbieri F; Cagnoli M; Schettini G
Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of ribozymes in haematological disorders.
James HA
Expert Opin Investig Drugs; 2000 May; 9(5):1009-20. PubMed ID: 11060723
[TBL] [Abstract][Full Text] [Related]
20. Ribozymes: structure, function, and potential therapy for dominant genetic disorders.
Grassi G; Marini JC
Ann Med; 1996 Dec; 28(6):499-510. PubMed ID: 9017109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
